Literature DB >> 15309974

The prevalence of blindness and low vision in older onset diabetes mellitus and associated factors: a community-based study.

A Idil1, D Caliskan, E Ocaktan.   

Abstract

PURPOSE: This community-based study was conducted to assess the prevalence and related factors of low vision and legal blindness in older onset diabetic patients (diagnosed at age 30 and older).
METHODS: All known diabetic patients who live in the four primary health care center region Abidinpaşa Ankara, Turkey (total population: 96,348) were included in this cross-sectional study. The prevalence of known diabetes mellitus is 2.2%, of which 96.6% are older onset and 3.4% are younger onset.
RESULTS: In the older onset diabetes group (1289 cases), 10.8% of the population had low vision and only 2.7% had legal blindness. Diabetic retinopathy (DR) was observed in 23.6% of the patients with low vision (42% proliferative DR) and in 62.9% of the patients with legal blindness (90.1 % proliferative DR).
CONCLUSIONS: In older onset diabetic patients with low vision, nonproliferative retinopathy was a more frequent cause of impaired vision than proliferative retinopathy. Low vision and legal blindness caused by retinopathy were significantly associated with sex, age at examination, age at diagnosis, duration of diabetes, type of diabetes treatment, and hypertension in univariate analysis. However, in logistic regression analysis, low vision and legal blindness caused by retinopathy were found to be associated with longer duration of diabetes (> or =15 years), use of insulin, and hypertension.

Entities:  

Mesh:

Year:  2004        PMID: 15309974     DOI: 10.1177/112067210401400404

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  7 in total

Review 1.  The prevalence of retinopathy among type 2 diabetic patients in Iran: A systematic review and meta-analysis.

Authors:  Masoud Mohammadi; Ali Akbar Vaisi Raiegani; Rostam Jalali; Akram Ghobadi; Nader Salari
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

2.  Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study.

Authors:  Niels de Fine Olivarius; Volkert Siersma; Gitte Juul Almind; Niels Vesti Nielsen
Journal:  BMC Public Health       Date:  2011-02-04       Impact factor: 3.295

3.  The effectiveness of nutritional education on the knowledge of diabetic patients using the health belief model.

Authors:  Gholamreza Sharifirad; Mohammad Hasan Entezari; Aziz Kamran; Leila Azadbakht
Journal:  J Res Med Sci       Date:  2009-01       Impact factor: 1.852

4.  Sensitivity and specificity of automated analysis of single-field non-mydriatic fundus photographs by Bosch DR Algorithm-Comparison with mydriatic fundus photography (ETDRS) for screening in undiagnosed diabetic retinopathy.

Authors:  Pritam Bawankar; Nita Shanbhag; S Smitha K; Bodhraj Dhawan; Aratee Palsule; Devesh Kumar; Shailja Chandel; Suneet Sood
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

5.  Prevalence and associated factors of visual impairment among adult diabetic patients visiting Adare General Hospital, Hawassa, South Ethiopia, 2022.

Authors:  Henok Biruk Alemayehu; Melkamu Temeselew Tegegn; Mikias Mered Tilahun
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

6.  Prevalence and causes of low vision and blindness in a Chinese population with type 2 diabetes: the Dongguan Eye Study.

Authors:  Ying Cui; Liang Zhang; Min Zhang; Xiaohong Yang; Lixin Zhang; Jian Kuang; Guanrong Zhang; Qingyang Liu; Haike Guo; Qianli Meng
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

7.  Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study.

Authors:  Mohammed Abdu Seid; Adugnaw Ambelu; Mengistie Diress; Yigizie Yeshaw; Yonas Akalu; Baye Dagnew
Journal:  BMC Ophthalmol       Date:  2022-02-03       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.